Skip to main content

Meningococcal group ABCWY vaccine

Generic name: meningococcal group ABCWY vaccine
Brand names: Penbraya, Penbraya (cvx 316)
Dosage form: intramuscular suspension (-)
Drug class: Bacterial vaccines

Medically reviewed by Drugs.com on Jan 29, 2024. Written by Cerner Multum.

What is meningococcal group ABCWY vaccine?

Meningococcal disease is a bacterial infection that can infect the spinal cord and brain, causing meningitis that can be fatal or lead to permanent and disabling medical problems.

Meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria is usually passed through close contact with an infected person, especially through kissing, or sharing a drinking glass or eating utensil.

Meningococcal group ABCWY vaccine is used to prevent infection caused by serogroup ABCWY meningococcal bacteria.

This vaccine helps your body develop immunity to meningitis, but will not treat an active infection you already have.

Meningococcal group ABCWY vaccine is for use in children and young adults who are 10 to 25 years old.

Like any vaccine, the meningococcal group ABCWY vaccine may not provide protection from disease in every person.

This vaccine side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Keep track of all side effects you have, be sure to tell the vaccination provider if the previous shot caused any side effects.

You should not receive a second shot if you had a life-threatening allergic reaction after the first shot.

Becoming infected with meningococcal disease and developing meningitis is much more dangerous to your health than receiving this vaccine. Any vaccine may cause side effects but the risk of serious side effects is low.

You may feel faint after receiving this vaccine. Your doctor may want you to remain under observation during the first 15 minutes after the injection.

Common side effects of meningococcal group ABCWY vaccine may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.

Warnings

You should not receive the vaccine a second time if you had a life threatening allergic reaction after the first shot.

Before taking this medicine

You should not receive this vaccine if you've ever had an allergic reaction to meningococcal vaccine.

Tell your doctor if you have ever had nervous system problems such as numbness, pain, tingling, weakness, burning or prickly feeling, vision or hearing problems, trouble breathing after receiving a vaccine.

This vaccine may need to be postponed or not given at all if you have:

You may still receive a vaccine if you have a minor cold.

Your doctor should determine if it is safe to receive this vaccine during pregnancy or while breastfeeding.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of this vaccine on the baby.

How is this vaccine given?

This vaccine is given as an injection (shot) into a muscle. You will receive this injection in a doctor's office or clinic setting.

Meningococcal group ABCWY vaccine is usually given in a series of 2 shots, the second shot is given 6 months after the first shot.

Be sure to receive all recommended doses of this vaccine or you may not be fully protected against disease.

There are other types of meningococcal vaccine available. When you receive your second dose, make sure you are receiving a vaccine for meningococcal serogroup A, B, C, W, or Y and not only for serogroup B, unless otherwise directed by your doctor or vaccination provider.

Meningococcal group ABCWY vaccine dosing information

Usual Adult Dose for Meningococcal Meningitis Prophylaxis:

Approximately 0.5 mL IM administered as 2 doses 6 months apart

Comment:
-This vaccine is approved for adults up to 25 years of age.

Use: For active immunization for the prevention of invasive disease caused by Neisseria meningitides serogroups A, B, C, W, and Y

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis:

10 to less than 18 years:
Approximately 0.5 mL IM administered as 2 doses 6 months apart

Use: For active immunization for the prevention of invasive disease caused by N meningitidis serogroups A, B, C, W, and Y

What happens if I miss a dose?

Contact your vaccination provider if you miss the second dose or if you get behind schedule.

What happens if I overdose?

An overdose of this vaccine is unlikely to occur.

What should I avoid before or after receiving this vaccine?

Follow your vaccination provider's instructions about any restrictions on food, beverages, or activity.

What other drugs will affect this vaccine?

Before receiving this vaccine, tell your doctor about all other vaccines you recently received.

Other drugs may affect meningococcal group ABCWY vaccine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

More about meningococcal group acwy conjugate-group b vaccine (cvx 316)

Patient resources

Other brands

Penbraya

Professional resources

Other brands

Penbraya

Related treatment guides

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.